Lazard secures Pfizer healthcare mandate

Pfizer, the US pharmaceuticals giant, has appointed long-standing adviser Lazard to explore strategic options for its consumer healthcare business, valued by one analyst at $10bn (€8.4bn).

A spokesman for Lazard confirmed the bank had been appointed. Pfizer was not immediately available for comment.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump